Join the Levonorgestrel group to help and get support from people like you.
Levonorgestrel News
Asthma Attacks Increase for Some Women Taking Progestogen-Only Pill
THURSDAY, May 8, 2025 – Use of a combined oral contraceptive (COC) is not associated with asthma in women of reproductive age, but use of a progestogen-only pill (POP) is associated with an...
Big Post-Election Surge Seen in Online Sales of Morning-After Pills
WEDNESDAY, Nov. 13, 2024 – In the wake of Donald Trump's victory in the presidential election, retailers report that online sales of emergency contraceptives have soared. The spike in purchases of...
Breast Cancer Risk Elevated With Levonorgestrel-Releasing Intrauterine System Use
FRIDAY, Oct. 18, 2024 – Women using levonorgestrel-releasing intrauterine systems (LNG-IUS) have an increased risk for breast cancer, according to a study published online Oct. 16 in the Journal of...
FDA Approves Medicines360’s Supplemental New Drug Application for Liletta (levonorgestrel-releasing intrauterine system) 52 mg as Treatment of Heavy Menstrual Bleeding
SAN FRANCISCO, CA – July 10, 2023 – Medicines360, a global nonprofit organization with a mission to catalyze equitable access to quality medicines for women, announced today that the U.S. Food and...
FDA Approves Medicines360’s Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Eight Years
SAN FRANCISCO – Nov. 14, 2022 – Medicines360, a global nonprofit organization with a mission to expand women’s access to quality medicines, announced today that the U.S. Food and Drug Administration ...
FDA Approves Extension of Mirena (levonorgestrel-releasing intrauterine system) Intrauterine Device (IUD) for up to Eight Years of Pregnancy Prevention
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer, a leader in women's healthcare, announced today that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) that...
FDA Medwatch Alert: Voluntary Recall of Certain Family Dollar Over-the-Counter Products
July 21, 2022 – Family Dollar is initiating a voluntary retail level product recall of certain products regulated by the U.S. Food and Drug Administration (FDA) that were stored and inadvertently...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Six Years
SAN FRANCISCO and DUBLIN October 28, 2019 – Medicines360, a global nonprofit organization with a mission to expand women’s access to quality medicines, and Allergan plc (NYSE: AGN), a leading global p...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Five Years
DUBLIN and SAN FRANCISCO October 16, 2018 – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women’s health pharmaceutical company with a mis...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Four Years
August 6, 2017 – Allergan plc (NYSE:AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women's health pharmaceutical company with a mission of expanding access to...
FDA Approves Bayer's Kyleena (Levonorgestrel-Releasing Intrauterine System) for Prevention of Pregnancy for up to Five Years
WHIPPANY, N.J., Sept. 19, 2016 /PRNewswire/ – Bayer announced today that the U.S. Food and Drug Administration (FDA) approved Kyleena (levonorgestrel-releasing intrauterine system) 19.5 mg, a...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Three Years
DUBLIN and SAN FRANCISCO, Feb. 27, 2015 /PRNewswire/ – Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical...
FDA Approves Plan B One-Step Emergency Contraceptive For Use Without A Prescription For All Women Of Child-Bearing Potential
June 20, 2013 – Today, the U.S. Food and Drug Administration announced it has approved the use of Plan B One-Step (levonorgestrel) as a nonprescription product for all women of child-bearing...
FDA Approves Plan B One-Step Emergency Contraceptive Without a Prescription for Women 15 Years of Age and Older
April 30, 2013 – The U.S. Food and Drug Administration today announced that it has approved an amended application submitted by Teva Women’s Health, Inc. to market Plan B One-Step (active ingredient ...
U.S. FDA Approves Bayer's Skyla (Levonorgestrel-Releasing Intrauterine System) 13.5 mg For Prevention Of Pregnancy For Up To Three Years
WAYNE, N.J., Jan. 9, 2013 /PRNewswire/ – Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Skyla (levonorgestrel-releasing intrauterine...
Further information
Related condition support groups
Emergency Contraception, Postcoital Contraception, Contraception, Birth Control
Related drug support groups
Plan B One-Step, Mirena, Aftera, Kyleena